134 related articles for article (PubMed ID: 29158497)
1. Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.
Kadalayil L; Khan S; Nevanlinna H; Fasching PA; Couch FJ; Hopper JL; Liu J; Maishman T; Durcan L; Gerty S; Blomqvist C; Rack B; Janni W; Collins A; Eccles D; Tapper W
Nat Commun; 2017 Nov; 8(1):1632. PubMed ID: 29158497
[TBL] [Abstract][Full Text] [Related]
2. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
3. The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.
Toomey S; Madden SF; Furney SJ; Fan Y; McCormack M; Stapleton C; Cremona M; Cavalleri GL; Milewska M; Elster N; Carr A; Fay J; Kay EW; Kennedy S; Crown J; Gallagher WM; Hennessy BT; Eustace AJ
Oncotarget; 2016 Nov; 7(46):75518-75525. PubMed ID: 27776352
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide association study of prognosis in breast cancer.
Azzato EM; Pharoah PD; Harrington P; Easton DF; Greenberg D; Caporaso NE; Chanock SJ; Hoover RN; Thomas G; Hunter DJ; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1140-3. PubMed ID: 20332263
[TBL] [Abstract][Full Text] [Related]
5. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.
Bao PP; Zhao ZG; Gao YT; Zheng Y; Zhang B; Cai H; Zheng W; Shu XO; Lu W
PLoS One; 2015; 10(2):e0117419. PubMed ID: 25679392
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
7. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
8. Common germline polymorphisms associated with breast cancer-specific survival.
Pirie A; Guo Q; Kraft P; Canisius S; Eccles DM; Rahman N; Nevanlinna H; Chen C; Khan S; Tyrer J; Bolla MK; Wang Q; Dennis J; Michailidou K; Lush M; Dunning AM; Shah M; Czene K; Darabi H; Eriksson M; Lambrechts D; Weltens C; Leunen K; van Ongeval C; Nordestgaard BG; Nielsen SF; Flyger H; Rudolph A; Seibold P; Flesch-Janys D; Blomqvist C; Aittomäki K; Fagerholm R; Muranen TA; Olsen JE; Hallberg E; Vachon C; Knight JA; Glendon G; Mulligan AM; Broeks A; Cornelissen S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Cross SS; Reed MW; Giles GG; Milne RL; McLean C; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning MJ; Hollestelle A; Martens JW; van den Ouweland AM; Marme F; Schneeweiss A; Yang R; Burwinkel B; Figueroa J; Chanock SJ; Lissowska J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Brenner H; Butterbach K; Holleczek B; Kataja V; Kosma VM; Hartikainen JM; Li J; Brand JS; Humphreys K; Devilee P; Tollenaar RA; Seynaeve C; Radice P; Peterlongo P; Manoukian S; Ficarazzi F; Beckmann MW; Hein A; Ekici AB; Balleine R; Phillips KA; ; Benitez J; Zamora MP; Perez JI; Menéndez P; Jakubowska A; Lubinski J; Gronwald J; Durda K; Hamann U; Kabisch M; Ulmer HU; Rüdiger T; Margolin S; Kristensen V; Nord S; ; Evans DG; Abraham J; Earl H; Poole CJ; Hiller L; Dunn JA; Bowden S; Yang R; Campa D; Diver WR; Gapstur SM; Gaudet MM; Hankinson S; Hoover RN; Hüsing A; Kaaks R; Machiela MJ; Willett W; Barrdahl M; Canzian F; Chin SF; Caldas C; Hunter DJ; Lindstrom S; Garcia-Closas M; Couch FJ; Chenevix-Trench G; Mannermaa A; Andrulis IL; Hall P; Chang-Claude J; Easton DF; Bojesen SE; Cox A; Fasching PA; Pharoah PD; Schmidt MK
Breast Cancer Res; 2015 Apr; 17(1):58. PubMed ID: 25897948
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
Kiyotani K; Mushiroda T; Tsunoda T; Morizono T; Hosono N; Kubo M; Tanigawara Y; Imamura CK; Flockhart DA; Aki F; Hirata K; Takatsuka Y; Okazaki M; Ohsumi S; Yamakawa T; Sasa M; Nakamura Y; Zembutsu H
Hum Mol Genet; 2012 Apr; 21(7):1665-72. PubMed ID: 22180457
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
11. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
12. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
Knechtel G; Hofmann G; Gerger A; Renner W; Langsenlehner T; Szkandera J; Wolf G; Samonigg H; Krippl P; Langsenlehner U
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1813-9. PubMed ID: 20204402
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional analysis of an ADAMTSL1 variant associated with a complex phenotype including congenital glaucoma, craniofacial, and other systemic features in a three-generation human pedigree.
Hendee K; Wang LW; Reis LM; Rice GM; Apte SS; Semina EV
Hum Mutat; 2017 Nov; 38(11):1485-1490. PubMed ID: 28722276
[TBL] [Abstract][Full Text] [Related]
14. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
15. Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.
Helleman J; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Klijn JG; Sleijfer S; Foekens JA; Berns EM
Clin Cancer Res; 2008 Sep; 14(17):5555-64. PubMed ID: 18765548
[TBL] [Abstract][Full Text] [Related]
16. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
[TBL] [Abstract][Full Text] [Related]
18. BRCA-associated breast cancer in young women.
Robson M; Gilewski T; Haas B; Levin D; Borgen P; Rajan P; Hirschaut Y; Pressman P; Rosen PP; Lesser ML; Norton L; Offit K
J Clin Oncol; 1998 May; 16(5):1642-9. PubMed ID: 9586873
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Pliarchopoulou K; Kalogeras KT; Kronenwett R; Wirtz RM; Eleftheraki AG; Batistatou A; Bobos M; Soupos N; Polychronidou G; Gogas H; Samantas E; Christodoulou C; Makatsoris T; Pavlidis N; Pectasides D; Fountzilas G
Cancer Chemother Pharmacol; 2013 Jan; 71(1):245-55. PubMed ID: 23096218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
